Stay updated with breaking news from Purecycle Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roth Mkm downgraded shares of PureCycle Technologies (NYSE:PCT – Free Report) from a buy rating to a neutral rating in a report released on Tuesday morning, Marketbeat.com reports. They currently have $3.00 price objective on the stock, down from their previous price objective of $6.00. Several other analysts have also recently commented on the company. […]
Roth Capital cut shares of PureCycle Technologies (NYSE:PCT – Free Report) from a buy rating to a neutral rating in a report released on Tuesday morning, PriceTargets.com reports. A number of other brokerages have also issued reports on PCT. Stifel Nicolaus decreased their target price on PureCycle Technologies from $15.00 to $6.00 and set a […]
-- PureCycle Technologies has an average rating of outperform and price targets ranging from $3 to $16, according to analysts polled by Capital IQ. Price: 2.9, Change: +0.1, Percent Change: +3.63 ...
Sanders Morris Harris LLC boosted its stake in PureCycle Technologies, Inc. (NYSE:PCT – Free Report) by 12.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 152,694 shares of the company’s stock after acquiring an additional 16,979 shares during the quarter. […]
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday.